Cytotoxic T lymphocyte responses to Marek's disease herpesvirus-encoded glycoproteins

Veterinary Immunology and Immunopathology

Volumn 90, Issue 3-4, 2002, Pages 133-144

  Markowski Grimsrud, Carrie J ^a,b   Schat, Karel A ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cell mediated immunity; Chickens; Cytotoxic T lymphocytes; Glycoprotein; Marek's disease herpesvirus; Reticuloendotheliosis virus

Indexed keywords

GLYCOPROTEIN D; ISOPROTEIN; THROMBOSPONDIN; VIRUS GLYCOPROTEIN; GLYCOPROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BIRD DISEASE; CELL LINE; CELL TRANSFORMATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; GENETIC TRANSFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; SPLEEN CELL; ANIMAL; CHICK EMBRYO; CHICKEN; CYTOTOXICITY; GENE EXPRESSION; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; VIROLOGY;

AVES; GALLUS GALLUS; HERPESVIRIDAE; RETICULOENDOTHELIOSIS VIRUS;

ANIMALS; CELL LINE; CHICK EMBRYO; CHICKENS; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION; GLYCOPROTEINS; HERPESVIRUS 2, GALLID; MAREK DISEASE; POULTRY DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 0036891566     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(02)00229-5     Document Type: Article

References (50)

1. Arvin A.M. Cell-mediated immunity to varicella-zoster virus. J. Infect. Dis. 166:1992;S35-41.
2. Arvin A.M., Sharp M., Smith S., Koropchak C.M., Diaz P.S., Kinchington P., Ruyechan W., Hay J. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. J. Immunol. 146:1991;257-264.
3. Beutner, E.H., Chorzelski, T.P., Kumar, V., 1987. Immunopathology of the Skin, 3rd Ed. Wiley, New York.
4. Binns M.M., Ross N.L.J. Nucleotide sequence of the Marek's disease virus (MDV) RB-1B A antigen and the identification of the MDV A antigen as the herpes simplex virus-2 glycoprotein C homologue. Virus Res. 12:1989;371-382.
5. Borysiewicz L.K., Sissons J.G.P. Cytotoxic T cells and human herpes simplex virus. Curr. Top. Microbiol. Immunol. 189:1994;123-150.
6. Brunovskis P., Velicer L.F. The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes. Virology. 206:1995;324-338.
7. Buckmaster A.E., Scott S.D., Sanderson M.J., Boursnell M.E., Ross N.L., Binns M.M. Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: implications for herpesvirus classification. J. Gen. Virol. 69:1988;2033-2042.
8. Bülow V.V., Biggs P.M. Differentiation between strains of Marek's disease virus and turkey herpesvirus by immunofluorescence assays. Avian Pathol. 4:1975;133-146.
9. Calnek B.W. Influence of age at exposure on the pathogenesis of Marek's disease. J. Natl. Cancer Inst. 51:1973;929-939.
10. Calnek B.W., Adldinger H.K., Kahn D.E. Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease. Avian Dis. 14:1970;219-233.
11. Calnek B.W., Schat K.A., Ross L.J., Shek W.R., Chen C.L. Further characterization of Marek's disease virus-infected lymphocytes. I. In vivo infection. Int. J. Cancer. 33:1984;389-398.
12. Calnek B.W., Harris R.W., Buscaglia C., Schat K.A., Lucio B. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates. Avian Dis. 42:1998;124-132.
13. Cardona C., Lucio B., O'Connell P., Jagne J., Schat K.A. Humoral immune responses to chicken infectious anemia virus in three strains of chickens in a closed flock. Avian Dis. 44:2000a;661-667.
14. Cardona C., Oswald W.B., Schat K.A. Distribution of chicken anaemia virus in the reproductive tissues of specific-pathogen-free chickens. J. Gen. Virol. 81:2000;2067-2075.
15. Hirai K., Sakaguchi M. Polyvalent recombinant Marek's disease virus vaccine against poultry diseases. Curr. Top. Microbiol. Immunol. 225:2001;261-287.
16. Kreager, K., 1997. Marek's disease: Clinical aspects and current field problems in layer chickens. In: Fadly, A.M., Schat, K.A., Spencer, J.L. (Eds.), Diagnosis and Control of Neoplastic Diseases of Poultry. American Association of Avian Pathologists, Kennett Square, PA, pp. 23-26.
17. Lupiani B., Lee L.F., Reddy S.M. Protein-coding content of the sequence of Marek's disease virus. Curr. Top. Microbiol. Immunol. 255:2001;159-190.
18. Markowski-Grimsrud, C.J., O'Connell, P., Schat, K.A., 2001. Syngeneic cell-mediated immune responses to Marek's disease virus-encoded glycoproteins. In: Schat, K.A., Morgan, R.M., Parcells, M.S., Spencer, J.L. (Eds.), Current Progress on Marek's Disease Research. American Association of Avian Pathologists, Kennett Square, PA, pp. 127-131.
19. Nazerian K., Lee L.F., Yanagida N., Ogawa R. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J. Virol. 66:1992;1409-1413.
20. Nazerian K., Witter R.L., Lee L.F., Yanagida N. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus. Avian Dis. 40:1996;368-376.
21. Omar, A.R., 1997. Cytotoxic T Lymphocyte Responses Against Marek's Disease Herpesvirus. Ph.D. Thesis. Cornell University, Ithaca, NY.
22. Omar A.R., Schat K.A. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins. Virology. 222:1996;87-99.
23. Omar A.R., Schat K.A. Characterization of Marek's disease herpesvirus (MDV)-specific cytotoxic T lymphocytes in chickens inoculated with a nononcogenic vaccine strain of MDV. Immunology. 90:1997;579-585.
24. Omar A.R., Schat K.A., Lee L.F., Hunt H.D. Cytotoxic T lymphocyte response in chickens immunized with a recombinant fowlpox virus expressing Marek's disease herpesvirus glycoprotein B. Vet. Immunol. Immunopathol. 62:1998;73-82.
25. Osterrieder N. Sequence and initial characterization of the U(L)10 (glycoprotein M) and U(L)11 homologous genes of serotype 1 Marek's disease virus arch. Virology. 144:1999;1853-1863.
26. Parcells M.S., Anderson A.S., Morgan R.W. Characterization of a Marek's disease virus mutant containing a lacZ insertion in the US6 (gD) homologue gene. Virus Gen. 9:1994;5-13.
27. Payne, L.N., 1985. Pathology. In: Payne, L.N. (Ed.), Marek's Disease. Martinus Nijhoff, Boston, pp. 43-75.
28. Ploegh H.L. Viral strategies of immune evasion. Science. 280:1998;248-253.
29. Pratt W.D., Morgan R., Schat K.A. Cell-mediated cytolysis of lymphoblastoid cells expressing Marek's disease virus-specific phosphorylated polypeptides. Vet. Microbiol. 33:1992;93-99.
30. Purchase, H.G., 1985. Clinical disease and its economic impact. In: Payne, L.N. (Ed), Marek's Disease. Martinus Nijhoff, Boston, pp. 17-24.
31. Ren D., Lee L.F., Coussens P.M. Identification and characterization of Marek's disease virus genes homologous to ICP27 and glycoprotein K of herpes simplex virus-1. Virology. 204:1994;242-250.
32. Rickinson A.B., Moss D.J. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Ann. Rev. Immunol. 15:1997;405-431.
33. Riddell S.R., Reusser P., Greenberg P.D. Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immunocompromised patients. Rev. Infect. Dis. 13:1991;S966-973.
34. Schat K.A., Markowski-Grimsrud C.J. Immune responses to Marek's disease virus. Curr. Top. Microbiol. Immunol. 225:2001;91-120.
35. Schat, K.A., Purchase, H.G., 1998. Cell-culture methods. In: Swayne, D.E., Glisson, J.R., Jackwood, M.W., Pearson, J.E., Reed, W.M., (Eds.), A Laboratory Manual for the Isolation and Identification of Avian Pathogens, 4th Ed. American Association of Avian Pathologists, Kennett Square, PA, pp. 223-234.
36. Schat K.A., Xing Z. Specific and nonspecific immune responses to Marek's disease virus. Dev. Comp. Immunol. 24:2000;201-221.
37. Schat K.A., Calnek B.W., Fabricant J. Characterisation of two highly oncogenic strains of Marek's disease virus. Avian Pathol. 11:1982;593-605.
38. Schat K.A., Shek W.R., Calnek B.W., Abplanalp H. Syngeneic and allogeneic cell-mediated cytotoxicity against Marek's disease lymphoblastoid tumor cell lines. Int. J. Cancer. 29:1982;187-194.
39. Schat K.A., Pratt W.D., Morgan R., Weinstock D., Calnek B.W. Stable transfection of reticuloendotheliosis virus-transformed lymphoblastoid cell lines. Avian Dis. 36:1992;432-439.
40. Schmid D.S., Mawle A.C. T cell responses to herpes simplex viruses in humans. Rev. Infect. Dis. 13:1991;S946-949.
41. Scott S.D., Smith G.D., Ross N.L.J., Binns M.M. Identification and sequence analysis of the homologues of the herpes simplex virus type 1 glycoprotein H in Marek's disease virus and the herpesvirus of turkeys. J. Gen. Virol. 74:1993;1185-1190.
42. Snedecor, G.W., Cochran, W.G., 1989. Statistical Methods, 8th Ed. Iowa State University Press, Ames, IA.
43. Tan X., Brunovskis P., Velicer L.F. Transcriptional analysis of Marek's disease virus glycoprotein D, I, and E genes: gD expression is undetectable in cell culture. J. Virol. 75:2001;2067-2075.
44. Uni Z., Pratt W.D., Miller M.M., O'Connell P.H., Schat K.A. Syngeneic lysis of reticuloendotheliosis virus-transformed cell lines transfected with Marek's disease virus genes by virus-specific cytotoxic T cells. Vet. Immunol. Immunopathol. 44:1994;57-69.
45. Weinstock, D., Schat, K.A., 1987. Virus specific syngeneic killing of reticuloendotheliosis virus transformed cell line target cells by spleen cells. In: Weber, W.T., Ewert, D.L.(Eds.), Avian Immunology. Alan R. Liss, New York, pp. 253-263.
46. Weinstock D., Schat K.A., Calnek B.W. Cytotoxic T lymphocytes in reticuloendotheliosis virus-infected chickens. Eur. J. Immunol. 19:1989;267-272.
47. Witter R.L. Increased virulence of Marek's disease virus field isolates. Avian Dis. 41:1997;149-163.
48. Witter R.L. Protective efficacy of Marek's disease vaccines. Curr. Top. Microbiol. Immunol. 255:2001;57-90.
49. Witter R.L., Calnek B.W., Kato S., Powell P.C. A proposed method for designating avian cell lines and transplantable tumours. Avian Path. 8:1979;487-498.
50. Yoshida S., Lee L.F., Yanagida N., Nazerian K. Identification and characterization of a Marek's disease virus gene homologous to glycoprotein L of herpes simplex virus. Virology. 204:1994;414-419.